Buffalo News4hOpinion
Boston Globe: 'Knock out the middlemen' is a campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
The Associated Press on MSN13d
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
During his 2023 State of the State tour, Newsom announced California would begin selling insulin for $30 a vial with a “2024 ...
pharmaphorum2d
Civica plans shake-up of insulin sector with low-cost biosimilars
The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine ... prices of the originator insulin are around $329 per vial and $510 for five pens, according to ...
Capital Public Radio13d
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
During his 2023 State of the State tour, Newsom announced California would begin selling insulin for $30 a vial with a “2024 ... at the pharmacy for Lantus, the brand name insulin glargine ...
Medscape2d
Room-temperature Storage of Medications Labeled for Refrigeration
28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...
pharmaphorum3d
Capping the cost of insulin: altruistic or strategic?
Novo Nordisk lowered the list price on various insulin products, including pre-filled insulin pens and vials. The company ... would cut the list price of its Lantus product by 78%, as well as ...